These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1724461)

  • 1. Pineal serotonin is resistant to depletion by serotonergic neurotoxins in rats.
    Champney TH; Matthews RT
    J Pineal Res; 1991; 11(3-4):163-7. PubMed ID: 1724461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of amphetamine-like designer drugs on monoaminergic systems in rat brain.
    Gibb JW; Stone DM; Stahl DC; Hanson GR
    NIDA Res Monogr; 1987; 76():316-21. PubMed ID: 2449619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    Farfel GM; Vosmer GL; Seiden LS
    Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-DOPA potentiation of the serotonergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats.
    Schmidt CJ; Black CK; Taylor VL
    Eur J Pharmacol; 1991 Oct; 203(1):41-9. PubMed ID: 1686766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of dopamine release by methylenedioxymethamphetamine is mediated by serotonin.
    Gazzara RA; Takeda H; Cho AK; Howard SG
    Eur J Pharmacol; 1989 Sep; 168(2):209-17. PubMed ID: 2575036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute melatonin and para-chloroamphetamine interactions on pineal, brain and serum serotonin levels as well as stress hormone levels.
    Manzana EJ; Chen WJ; Champney TH
    Brain Res; 2001 Aug; 909(1-2):127-37. PubMed ID: 11478929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.
    Ricaurte GA; Martello AL; Katz JL; Martello MB
    J Pharmacol Exp Ther; 1992 May; 261(2):616-22. PubMed ID: 1374470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.
    Battaglia G; Yeh SY; De Souza EB
    Pharmacol Biochem Behav; 1988 Feb; 29(2):269-74. PubMed ID: 2452449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K; Maeda H; Goromaru T
    Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain.
    Schmidt CJ; Levin JA; Lovenberg W
    Biochem Pharmacol; 1987 Mar; 36(5):747-55. PubMed ID: 2881549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue.
    Schmidt CJ; Wu L; Lovenberg W
    Eur J Pharmacol; 1986 May; 124(1-2):175-8. PubMed ID: 2424776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT; Nash JF; Meltzer HY
    Eur J Pharmacol; 1989 Apr; 163(1):157-61. PubMed ID: 2472965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.
    Hashimoto K; Maeda H; Goromaru T
    Eur J Pharmacol; 1992 Sep; 228(2-3):171-4. PubMed ID: 1280228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
    Gu XF; Azmitia EC
    Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.